Sotera Health (NASDAQ:SHC) Rating Increased to Strong-Buy at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Sotera Health (NASDAQ:SHC) to a strong-buy rating in a research note released on Friday,Zacks.com reports.

SHC has been the subject of several other research reports. Piper Sandler reiterated an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Barclays dropped their price objective on Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Weiss Ratings cut Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Citigroup increased their price objective on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Finally, Wall Street Zen cut Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Sotera Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.29.

Sotera Health Price Performance

SHC opened at $15.62 on Friday. The stock’s 50 day simple moving average is $15.37 and its 200 day simple moving average is $16.36. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. Sotera Health has a 1 year low of $10.80 and a 1 year high of $19.85. The firm has a market cap of $4.45 billion, a price-to-earnings ratio of 38.10 and a beta of 1.79.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. During the same period last year, the company earned $0.14 EPS. Sotera Health’s revenue for the quarter was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, analysts predict that Sotera Health will post 0.86 earnings per share for the current year.

Insider Activity at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 15.36% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in SHC. Sculptor Capital LP lifted its stake in shares of Sotera Health by 57.4% in the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after purchasing an additional 7,658,200 shares during the period. Sachem Head Capital Management LP lifted its stake in shares of Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after purchasing an additional 3,735,000 shares during the period. Vanguard Group Inc. lifted its stake in shares of Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock valued at $339,189,000 after purchasing an additional 2,756,583 shares during the period. AQR Capital Management LLC lifted its stake in shares of Sotera Health by 1,206.2% in the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock valued at $50,523,000 after purchasing an additional 2,644,831 shares during the period. Finally, Norges Bank purchased a new position in shares of Sotera Health in the 4th quarter valued at approximately $45,278,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.